ABSTRACT
The proceedings contain 205 papers. The topics discussed include: preparing long-term care facilities for future pandemics - a systematic review of non-pharmacological interventions;and pandemic management: analysis of availability and relevance of surveillance indicators by COVID-task-forces in the state of Lower Saxony.
ABSTRACT
The proceedings contain 238 papers. The topics discussed include: treatment with tofacitinib attenuates muscle loss through Myogenin activation in collagen-induced arthritis;plasma cytokine levels in a group of Colombian patients with moderate systemic lupus erythematosus and rheumatoid arthritis;prevalence of neoplastic disease in patients with systemic sclerosis in a south American cohort;characterization of rheumatic manifestations in patients with HIV infection from a south American hospital;anthropometric measures of central adiposity in the evaluation of metabolic syndrome in patients with idiopathic inflammatory myopathies;anti RO 52/60 antibodies and their clinical serological correlation. single center descriptive study;safety and immunogenicity of CoronaVac and CHADOX1 vaccines against SARS-COV-2 in patients with rheumatoid arthritis: Brazilian multicentric study;and effect of ABO and RH blood type on SARS-COV-2 infection severity in patients with rheumatic diseases: data from the national SAR-COVID registry.
ABSTRACT
Informed Consent Statements and Conflict of Interest Statements were not included in the published version of the following articles that appeared in previous issues of Clinical Immunology Communications. The appropriate Consent Statements and Conflict of Interest Statements, provided by the Authors, are included below: 1 "Pfizer-biontech COVID-19 RNA vaccination induces phosphatidylserine autoantibodies, cryoglobulinemia, and digital necrosis in a patient with pre-existing autoimmunity"[[Clinical Immunology Communications, 2022, Vol 1 Pages 1-3] https://doi.org/10.1016/j.clicom.2021.08.001 Informed Patient Consent: Complete written informed consent was obtained from the patient for the publication of this study and accompanying images. Consent was obtained to use body samples and materials for research on April 19, 2021. 2 "Altered pre-existing SARS-CoV-2-specific T cell responses in elderly individuals" [Clinical Immunology Communications, 2022, Vol 2 Pages 6-11] https://doi.org/10.1016/j.clicom.2021.12.001 Conflict of Interest: We declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Hiroki Ishikawa and Mary K Collins are co-inventors of the patent application related to this work. 3 "Successful desensitization in a patient with adalimumab hypersensitivity" [Clinical Immunology Communications, 2022, Vol 2 Pages 30-32] https://doi.org/10.1016/j.clicom.2021.12.003 Informed Patient Consent: Complete written informed consent was obtained from the patient for the publication of this study and accompanying images. 4 "Pharmacokinetics of convalescent plasma therapy in a COVID-19 patient with X-linked Agammaglobulinemia" [Clinical Immunology Communications, 2022, Vol 2 Pages 57-61] https://doi.org/10.1016/j.clicom.2022.03.001 Informed Patient Consent: Complete written informed consent was obtained from the patient for the publication of this study and accompanying images. The authors assert that written informed consent was obtained for the donor stored sample but not the decedent as required by the Albany Medical Center IRB. 5 "Appraising SARS-CoV-2 infections after full mRNA COVID-19 vaccination in patients with systemic lupus erythematosus (SLE)" [Clinical Immunology Communications, 2022, Vol 2 Pages 54-56] https://doi.org/10.1016/j.clicom.2022.03.002 Informed Patient Consent: The authors declare that informed patient consent was not provided for the following reason: Informed consent was not required per Upstate IRB Policy, because the data was de-identified and no images were included in the case series. 6 "Meningoradiculitis post-COVID-19 mRNA vaccination: A case report" [Clinical Immunology Communications, 2022, Vol 2 Pages 76-78] https://doi.org/10.1016/j.clicom.2022.03.004 Informed Patient Consent: Complete written informed consent was obtained from the patient for the publication of this study and accompanying images. 7 "A case of de novo seronegative inflammatory oligoarthritis associated with COVID-19 infection." [Clinical Immunology Communications, 2022, Vol 2 Pages 159-161] https://doi.org/10.1016/j.clicom.2022.10.001 Informed Patient Consent: No patient identifying information was used in this publication. All potentially HIPAA defined information was omitted from the writing and images used in this report in order to protect the anonymity of the patient. 8 "Predictors of mortality in patients with COVID-19 by flow cytometry" [Clinical Immunology Communications, 2022, Vol 2 Pages 6-11] https://doi.org/10.1016/j.clicom.2023.02.003 Conflict of Interest: No conflict of interest exists. We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.Copyright © 2023
ABSTRACT
The proceedings contain 343 papers. The topics discussed include: implementation of a disease modifying anti-rheumatic drug blood monitoring software: 8 years of experience in a single center;effectiveness of colchicine among patients with COVID-19 infection: a randomized, open labelled, clinical trial;rheumatic autoimmune diseases following COVID-19 infection: an observational study in Iraqi Kurdistan region;COVID-19 in male elite Irish-based athletes at a national sports institute;the effects of a pain management program for patients with an inflammatory arthritis;a retrospective analysis of the effectiveness safety of platelet rich plasma injections in primary osteoarthritis in knee joint, in patients attending a tertiary care hospital, Sri Lanka;a cohort study;do proformas used in fracture liaison service appointments reflect national osteoporosis clinical standards? a content analysis;calcium pyrophosphate dihydrate crystal in operated rheumatoid arthritis of the knee;cardiac amyloidosis: a case series of 31 patients with a comprehensive literature review;scoping review for the application of center of pressure for patient or intervention assessment in rheumatoid conditions;and four SNPs associated with monocyte/macrophage cell lineage uniquely associated with CRPS-1 in discovery and replication cohorts and suggest predisposition to regional osteopenia and digit misperception.
ABSTRACT
The proceedings contain 159 papers. The topics discussed include: microelimination of hepatitis C among people living with diagnosed HIV in England;laboratory implementation of emergency department blood-borne virus (EDBBV) opt-out screening in a London tertiary center;a review of sexual health and blood-borne virus care provided to inmates at admission into UK prisons and secure facilities;implementation of routine opt-out blood-borne virus (BBV) screening in 34 emergency departments (EDs) in areas of extremely high HIV prevalence in England;impact and experiences of offering HIV testing across the whole city population through primary care clusters and GP surgeries in the texting 4 Testing (T4T) project;'Not PrEPared': barriers to accessing PrEP in England;HIV care during the SARS-COV-2 pandemic for Black people with HIV in the UK;clinical presentation of mpox in people with and without HIV;and 'if you don't know, how can you know?': a qualitative investigation of HIV pre-exposure prophylaxis knowledge and perceptions among women in England.
ABSTRACT
[...]in this case, the Pfizer/BioNTech response-which is appropriate-is that if the level of antibodies is too low, we may need a third dose in the age group of 2 to 5 years. All that said, it seems the existing vaccines now have a 3-dose series in adults;we don't know necessarily yet for children if 2 or 3 doses will be necessary for all the mRNA vaccines, but there are reasonably good data that the immune responses induced may still provide a level of protection that is reasonable. Whenever there is a new variant, there are basic science laboratories in various parts of the world that are poised to immediately do studies with model systems in which they can put the variants into a virus that is not pathogenic and ask the question "Do the antibodies from some of the recipients of the vaccine provide some level of protection in a laboratory study?" With the Omicron surge being so big, we were able to get a pretty good idea of whether people who had received the vaccine were significantly less likely to have significant consequences from infection. William J. Muller is an attending physician of infectious diseases and scientific director of clinical and community trials at the Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago and an associate professor of pediatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
ABSTRACT
The proceedings contain 91 papers. The topics discussed include: the new approach of COVID-19 patients with deteriorating respiratory functions using perfusion SPECT/CT imaging;increasing interest in nuclear medicine: evaluation of an educational workshop;cost-benefit analysis recommends further utilization of cardiac PET/MR for sarcoidosis evaluation;development of a nomogram model for predicting the recurrence of differentiated thyroid carcinoma patients based on a thyroid cancer database from a tertiary hospital in China;multi-center validation of radiomic models in new data using ComBat-based harmonization of features;bone scan with Tc99m-MDP, the missing link in the initial staging of muscle-invasive bladder carcinoma;and comparison of absorbed doses to kidneys calculated employing three time points and employing two time points in neuroendocrine patients undergoing Lu-177 DOTATATE therapy using planar images.
ABSTRACT
Schools should focus on the following key areas: 1 Mental health staff Staffing schools with mental health specialists, including psychologists and licensed independent clinical social workers, will be helpful. Increased training is also important for school-based health center staff who have access to consultative support from mental health professionals. 2Telehealth The COVID-19 pandemic hastened the expansion of telehealth services, particularly in the area of mental health. Pediatricians should ask families whether any changes in behaviors or development should be supported by services outside of school. 4 Cross-sector partnerships The United Health Foundation is supporting an innovative partnership at Children's National Hospital in Washington, DC, between a pediatric primary care medical home, pediatric mobile medical services, schools, early childhood development centers, and other community organizations.7 School absenteeism can be an early markerfor children's untreated medical and behavioral issues as well as family stressors.
ABSTRACT
The proceedings contain 63 papers. The topics discussed include: a retrospective study to optimize post-anesthetic recovery time after ambulatory lower limb orthopedic procedures at a tertiary care hospital in Canada;a virtual airway evaluation as good as the real thing?;airway management during in hospital cardiac arrest by a consultant led airway management team during the COVID-19 pandemic: a prospective and retrospective quality assurance project;prevention of cautery induced airway fire using saline filled endotracheal tube cuffs: a study in a trachea airway fire model;smart phone assisted retrograde illumination versus conventional laryngoscope illumination for orotracheal intubation: a prospective comparative trial;time to single lung isolation in massive pulmonary hemorrhage simulation using a novel bronchial blocker and traditional techniques;cannabinoid type 2 receptor activation ameliorates acute lung injury induced systemic inflammation;bleeding in patients with end-stage liver disease undergoing liver transplantation and fibrinogen level: a cohort study;endovascular Vena Cavae occlusion in right anterior mini-thoracoscopic approach for tricuspid valve in patients with previous cardiac surgery;and mesenchymal stem cell extracellular vesicles as a novel, regenerative nanotherapeutic for myocardial infarction: a preclinical systematic review.
ABSTRACT
The proceedings contain 35 papers. The topics discussed include: germline variants and prognostic factors for cutaneous melanoma in children and adolescents;association between polygenic risk score and multiple primary melanoma;Porocarcinoma: an epidemiological, clinical, and dermoscopic 20-year study;primary cutaneous melanoma and COVID-19: a hospital-based study;atypical spitz tumors: an epidemiological, clinical and dermoscopic multicenter study with 16 years of follow-up;pediatric melanoma: an epidemiological, clinical and dermoscopic multicenter study;recurrence-free survival prediction in melanoma patients by exploiting artificial intelligence techniques on melanoma whole slide images;ultra-high frequency ultrasound and machine learning approaches for the differential diagnosis of melanocytic lesions;and genetic determinants of response to therapy in a real-world setting of advanced/metastatic melanoma patients: whole-exome sequencing and CFDNA analysis.
ABSTRACT
At the request of the authors, the Editors and Publisher retract the article Use of Antimicrobial Peptides Against SARS-CoV-2: Today is the Future by Alsabony et al.1 published post-acceptance on January 20, 2021 in Infectious Microbes & Diseases. The content and structure of this article display high similarity with another article that is currently under review for consideration of publication in another journal. The authors, the Editors and Publisher all agree that this article is not suitable to be published.Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.